Pembrolizumab for HER2+ gastric cancer
- PMID: 34937950
- DOI: 10.1038/s41571-021-00594-x
Pembrolizumab for HER2+ gastric cancer
Comment on
-
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer.Nature. 2021 Dec;600(7890):727-730. doi: 10.1038/s41586-021-04161-3. Epub 2021 Dec 15. Nature. 2021. PMID: 34912120 Free PMC article. Clinical Trial.
References
Original article
-
- Janjigian, Y. Y. et al. The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer. Nature https://doi.org/10.1038/s41586-021-04161-3 (2021) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous